Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid
- PMID: 24189251
- PMCID: PMC3910754
- DOI: 10.1128/AAC.01499-13
Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid
Abstract
Pentavalent antimonial drugs such as meglumine antimoniate (Glucantime [Glu; Sanofi-Aventis, São Paulo, Brazil]) produce severe side effects, including cardiotoxicity and hepatotoxicity, during the treatment of leishmaniasis. We evaluated the role of residual Sb(III) in the hepatotoxicity of meglumine antimoniate, as well as the protective effect of the antioxidant ascorbic acid (AA) during antimonial chemotherapy in a murine model of visceral leishmaniasis. BALB/c mice infected with Leishmania infantum were treated intraperitoneally at 80 mg of Sb/kg/day with commercial meglumine antimoniate (Glu) or a synthetic meglumine antimoniate with lower Sb(III) level (MA), in association or not with AA (15 mg/kg/day), for a 20-day period. Control groups received saline or saline plus AA. Livers were evaluated for hepatocytes histological alterations, peroxidase activity, and apoptosis. Increased proportions of swollen and apoptotic hepatocytes were observed in animals treated with Glu compared to animals treated with saline or MA. The peroxidase activity was also enhanced in the liver of animals that received Glu. Cotreatment with AA reduced the extent of histological changes, the apoptotic index, and the peroxidase activity to levels corresponding to the control group. Moreover, the association with AA did not affect the hepatic uptake of Sb and the ability of Glu to reduce the liver and spleen parasite loads in infected mice. In conclusion, our data supports the use of pentavalent antimonials with low residue of Sb(III) and the association of pentavalent antimonials with AA, as effective strategies to reduce side effects in antimonial therapy.
Figures
Similar articles
-
Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.Antimicrob Agents Chemother. 2017 Oct 24;61(11):e00962-17. doi: 10.1128/AAC.00962-17. Print 2017 Nov. Antimicrob Agents Chemother. 2017. PMID: 28827416 Free PMC article.
-
Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.Chem Biol Interact. 2006 Apr 15;160(3):217-24. doi: 10.1016/j.cbi.2006.01.008. Epub 2006 Mar 9. Chem Biol Interact. 2006. PMID: 16524568
-
Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.Antimicrob Agents Chemother. 2017 May 24;61(6):e02360-16. doi: 10.1128/AAC.02360-16. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28320726 Free PMC article.
-
Visceral leishmaniasis in paediatrics.Curr Opin Infect Dis. 2002 Jun;15(3):289-94. doi: 10.1097/00001432-200206000-00012. Curr Opin Infect Dis. 2002. PMID: 12015464 Review.
-
[Treatment of visceral leishmaniasis in children].Med Trop (Mars). 2007 Feb;67(1):73-8. Med Trop (Mars). 2007. PMID: 17506279 Review. French.
Cited by
-
Supramolecular assemblies from antimony(V) complexes for the treatment of leishmaniasis.Biophys Rev. 2023 Jun 6;15(4):751-765. doi: 10.1007/s12551-023-01073-6. eCollection 2023 Aug. Biophys Rev. 2023. PMID: 37681109 Review.
-
Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis-An updated review.Front Bioeng Biotechnol. 2022 Dec 14;10:1016925. doi: 10.3389/fbioe.2022.1016925. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36588956 Free PMC article. Review.
-
Effects of a Serine Protease Inhibitor N-p-Tosyl-L-phenylalanine Chloromethyl Ketone (TPCK) on Leishmania amazonensis and Leishmania infantum.Pharmaceutics. 2022 Jun 29;14(7):1373. doi: 10.3390/pharmaceutics14071373. Pharmaceutics. 2022. PMID: 35890269 Free PMC article.
-
Investigation of Cytotoxicity of Biosynthesized Colloidal Nanosilver against Local Leishmania tropica: In Vitro Study.Materials (Basel). 2022 Jul 13;15(14):4880. doi: 10.3390/ma15144880. Materials (Basel). 2022. PMID: 35888346 Free PMC article.
-
Ascorbic Acid Ameriolates Liver Damage by Myeloperoxidase Oxidative Products in a Hamster Model of Amoebic Liver Abscess.Front Cell Infect Microbiol. 2022 Mar 22;12:855822. doi: 10.3389/fcimb.2022.855822. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35392606 Free PMC article.
References
-
- Vianna G. 1912. Tratamento da leishmaniose tegumentar por injeções intravenosas de tártaro emético. Ann. 7th Cong. Bras. Med. Cirurg. 4:426–428
-
- Marsden PD. 1985. Pentavalent antimonials: old drugs for new diseases. Rev. Soc. Bras. Med. Trop. 18:187–198. 10.1590/S0037-86821985000300011 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
